Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III

American Journal of Cardiology

Volumn 79, Issue 6, 1997, Pages 834-838

  Lee, Philip J ^a,b,c   Deanfield, John E ^a,b,c   Burch, Michael ^a,b,c   Baig, Kamran ^a,b,c   McKenna, William J ^a,b,c   Leonard, James V ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CORONARY RISK; ELECTROCARDIOGRAPHY MONITORING; EXERCISE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 3; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; MALE; PHYSICAL STRESS; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT; MALE;

EID: 0030945233     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00885-5     Document Type: Article

References (20)

1. Ding J-H, de Barsy T, Brown BI, Coleman RA, Chen Y-T. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr. 116:1990;95-100.
2. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen Y-T. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med. 116:1992;896-900.
3. Chen Y-T, Burchell A. Glycogen storage diseases. Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. 1995;935-965 McGraw-Hill, New York.
4. Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr. 148:1989;764-766.
5. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV. Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol. 53:1984;980-981.
6. Tada H, Kurita T, Ohe T, Shimomura K, Ishihara T, Yamada Y, Osawa N. Glycogen storage disease type III associated with ventricular tachycardia. Am Heart J. 130:1995;911-912.
7. Miller CG, Alleyne GA, Brooks SEH. Gross cardiac involvement in glycogen storage disease type III. Br Heart J. 34:1972;862-864.
8. Rossignol A-M, Meyer M, Rossignol B, Palcoux M-P, Raynaud E-J, Bost M. La myocardiopathie de la glycogenose type III. Arch Franc Pediatr. 36:1979;303-309.
9. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation. 80:1989;1489-1492.
10. Sadoul N, Saumarez RC, McKenna WJ. Identification of high-risk patients with hypertrophic cardiomyopathy. Cardiol Rev. 3:1995;44-52.
11. Gillard BK, Nelson TE. Amylo-1,6-glucosidase/4-a-glucan-transferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme. Biochemistry. 16:1977;3978-3987.
12. Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W. Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol. 22:1993;1189-1192.
13. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 44:1980;672-673.
14. Bruce RA. Exercise testing of patients with coronary heart disease: principles and normal standards for evaluation. Ann Clin Res. 3:1971;323-332.
15. Takata J, Counihan PJ, Gane JN, Doi Y, Chikamori T, Ozawa T, McKenna WJ. Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain. Am J Cardiol. 72:1993;211-217.
16. Gould KL, Westcott RJ, Albro PC, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardal imaging and pharmacologic coronary vasodilation. II. Clinical methodology and feasibility. Am J Cardiol. 41:1978;279-287.
17. McKenna W, Deanfield J, Farqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 47:1981;532-538.
18. Toyota H, Kurokawa S, Tanaka H, Baba S, Kobayashi M, Nakaya R, Kawanishi M. Case of glycogenosis III with marked fibrosis of the myocardium and cardiac failure. J Jpn Soc Intern Med. 81:1992;583.
19. Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation. 82:1990;1995-2002.
20. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular response to supine exercise in hypertrophic cardiomyopathy. Circulation. 84:1991;686-696.